Remove Clinic Remove Disease Remove Magnetic Resonance Imaging
article thumbnail

Coding changes that will impact diagnostic and interventional radiology practices in 2025

AuntMinnie

55881 Ablation of prostate tissue, transurethral, using thermal ultrasound, including magnetic resonance imaging guidance for, and monitoring of, tissue ablation. CM stands for the Clinical Modification of the classification system. PC-6.47 $525.63 $209.28 PC-14.56 $8,508.75 $470.97 48.96 $1,583.68 37.11 $1,200.38

article thumbnail

FDA authorizes AI-driven MRI Solution for Safer Alzheimer’s Treatment

Imaging Technology

A large study, needed for FDA clearance, demonstrated that the use of icobrain aria significantly increases the accuracy of ARIA assessments by radiologists and hence allows for safer use of new amyloid-beta targeting therapies for Alzheimer’s disease patients. icobrain aria was thoroughly evaluated in large reader studies.

MRI 111
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Magnetic Resonance-guided Focused Ultrasound in Intracranial Diseases

Imaging Technology

Food and Drug Administration has approved this technology for the treatment of essential tremor and Parkinson's disease, and its indications are expanding to include various intracranial diseases. High-intensity FUS is a safe and effective treatment for various intracranial diseases.

Disease 105
article thumbnail

Brainet and SimonMed Partner to Advance Diagnosis of Neurodegenerative Diseases Using AI and Advanced Imaging Techniques

Imaging Technology

Integrating AI with our advanced imaging techniques will allow us to detect subtle changes in brain activity indicative of neurodegenerative diseases at their nascent stage.

Disease 116
article thumbnail

Research Spotlight: Validating an MRI Biomarker for Early Onset Alzheimer’s Disease

Imaging Technology

Is there a signature biomarker for younger/early-onset Alzheimer’s Disease (EOAD)? Sporadic early-onset Alzheimer’s disease (EOAD) is rare and understudied. Sporadic early-onset Alzheimer’s disease (EOAD) is rare and understudied. What Are the Clinical Implications? What Question Were You Investigating?

Disease 111
article thumbnail

UCSF, GE HealthCare Launch Joint Research Program to Drive Innovation

Imaging Technology

The Care Innovation Hub leverages the strengths of academia and industry to create, evaluate and translate novel technology into a clinical setting with the goals of advancing diagnosis and treatment of disease, improving hospital operations and driving more equitable access to care. tim.hodson Mon, 01/27/2025 - 10:11 Jan.

article thumbnail

Terran Biosciences Receives FDA Clearance for NM-101, the Industry’s First Software for the analysis of Neuromelanin-sensitive MRI

Imaging Technology

We believe this technology could become very important in the clinical workflow of patients with neurological and psychiatric disorders.” While neuromelanin was first described in the 19 th century, researchers have elucidated its possible role as a biomarker for neurological disorders such as Parkinson’s disease in the last two decades.